Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Orgenesis Inc | ORGS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.5149 | 04:16:39 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.5149 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.25 - 1.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.5149 | USD |
Orgenesis Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 16.26M | 31.88M | - | 530k | -55.36M | -1.74 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Orgenesis News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ORGS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.475 | 0.5298 | 0.45 | 0.4956346 | 21,373 | 0.0399 | 8.40% |
| 1 Month | 0.545 | 0.6349 | 0.45 | 0.5271586 | 34,187 | -0.0301 | -5.52% |
| 3 Months | 0.871 | 0.913 | 0.3044 | 0.5305733 | 170,360 | -0.3561 | -40.88% |
| 6 Months | 0.42 | 0.913 | 0.25 | 0.5015789 | 160,508 | 0.0949 | 22.60% |
| 1 Year | 1.20 | 1.50 | 0.25 | 0.5753594 | 117,593 | -0.6851 | -57.09% |
| 3 Years | 5.01 | 5.85 | 0.25 | 1.88 | 85,392 | -4.50 | -89.72% |
| 5 Years | 4.31 | 12.00 | 0.25 | 3.70 | 100,539 | -3.80 | -88.05% |
Orgenesis Description
| Orgenesis Inc is a global biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). Its geographical segments include Korea, United Arab Emirates, China, India, and Greece. |
